Natriuretic Peptides and Their Chimerics in Hypertension (Aims 1 and 2)
Phase of Trial: Phase I/II
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Nesiritide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Dec 2016 Status changed from suspended to discontinued.
- 08 Nov 2013 Planned end date changed from 1 Jan 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov record.